Bumetanide is Not Beneficial for Treating Pediatric Autism Spectrum Disorder

Phase 3 trial results demonstrate that bumetanide oral solution is not superior to placebo in treating ASD in children and adolescents.

Related Keywords

,Autism Research ,Childhood Autism Rating Scale ,Social Responsiveness ,Clinical Global Impressions Improvement Scale ,Vineland Adaptive Behavior Scale ,